APA (7th ed.) Citation

Albash, R., Ali, S. K., Abdelmonem, R., Agiba, A. M., Aldhahri, R., Saleh, A., . . . Abdellatif, M. M. (2025). Electrospun Nanofiber-Scaffold-Loaded Levocetirizine Dihydrochloride Cerosomes for Combined Management of Atopic Dermatitis and Methicillin-Resistant Staphylococcus Aureus (MRSA) Skin Infection: In Vitro and In Vivo Studies. Pharmaceuticals (14248247), 18(5), 633. https://doi.org/10.3390/ph18050633

Chicago Style (17th ed.) Citation

Albash, Rofida, Samer Khalid Ali, Rehab Abdelmonem, Ahmed M. Agiba, Renad Aldhahri, Asmaa Saleh, Amira B. Kassem, and Menna M. Abdellatif. "Electrospun Nanofiber-Scaffold-Loaded Levocetirizine Dihydrochloride Cerosomes for Combined Management of Atopic Dermatitis and Methicillin-Resistant Staphylococcus Aureus (MRSA) Skin Infection: In Vitro and In Vivo Studies." Pharmaceuticals (14248247) 18, no. 5 (2025): 633. https://doi.org/10.3390/ph18050633.

MLA (9th ed.) Citation

Albash, Rofida, et al. "Electrospun Nanofiber-Scaffold-Loaded Levocetirizine Dihydrochloride Cerosomes for Combined Management of Atopic Dermatitis and Methicillin-Resistant Staphylococcus Aureus (MRSA) Skin Infection: In Vitro and In Vivo Studies." Pharmaceuticals (14248247), vol. 18, no. 5, 2025, p. 633, https://doi.org/10.3390/ph18050633.